Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/4/25 18:18 | 2/3/25 | ATYR | Health | BioPrd | Biological Products, (No Diag | Shukla Sanjay | CA | DO | P,CEO | 1 | M.d | 0 | 0.00 | 0 | 10 | 8 | 147 | D | ||||||||||||||
2/4/25 18:14 | 2/3/25 | ATYR | Health | BioPrd | Biological Products, (No Diag | Broadfoot Jill Marie | CA | O | CFO | 2 | M.d | 5 | 0.9472 | 0 | 5 | 19 | 32 | D | ||||||||||||||
2/4/25 18:14 | 2/4/25 | ATYR | Health | BioPrd | Biological Products, (No Diag | Broadfoot Jill Marie | CA | O | CFO | 2 | S.d | -5 | 0.9472 | 0 | -5 | 32 | D | |||||||||||||||
2/4/25 18:11 | 2/3/25 | ATYR | Health | BioPrd | Biological Products, (No Diag | Denyes Nancy | CA | O | GC | 2 | M.d | 3 | 0.9476 | 0 | 4 | 16 | 27 | D | ||||||||||||||
2/4/25 18:11 | 2/4/25 | ATYR | Health | BioPrd | Biological Products, (No Diag | Denyes Nancy | CA | O | GC | 2 | S.d | -3 | 0.9476 | 0 | -4 | 27 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |